Works matching IS 00071188 AND DT 2023 AND VI 180 AND IP 3
Results: 9
Guidance for the use and reporting of anaesthetic agents in BJP manuscripts involving work with animals.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 3, p. 255, doi. 10.1111/bph.15992
- By:
- Publication type:
- Article
Recent therapeutic approaches to cystathionine beta‐synthase‐deficient homocystinuria.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 3, p. 264, doi. 10.1111/bph.15991
- By:
- Publication type:
- Article
Targeted delivery of triptolide by dendritic cell‐derived exosomes for colitis and rheumatoid arthritis therapy in murine models.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 3, p. 330, doi. 10.1111/bph.15958
- By:
- Publication type:
- Article
Hypothesis: Efficacy of early treatments with some NSAIDs in COVID‐19: Might it also depend on their direct and/or indirect zinc chelating ability?
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 3, p. 279, doi. 10.1111/bph.15989
- By:
- Publication type:
- Article
Aberrant branched‐chain amino acid accumulation along the microbiota–gut–brain axis: Crucial targets affecting the occurrence and treatment of ischaemic stroke.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 3, p. 347, doi. 10.1111/bph.15965
- By:
- Publication type:
- Article
Icariside II preconditioning evokes robust neuroprotection against ischaemic stroke, by targeting Nrf2 and the OXPHOS/NF‐κB/ferroptosis pathway.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 3, p. 308, doi. 10.1111/bph.15961
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 3, p. 253, doi. 10.1111/bph.15871
- Publication type:
- Article
Cannabinoid 1 (CB<sub>1</sub>) receptor arrestin subtype‐selectivity and phosphorylation dependence.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 3, p. 369, doi. 10.1111/bph.15973
- By:
- Publication type:
- Article
Asebogenin suppresses thrombus formation via inhibition of Syk phosphorylation.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 3, p. 287, doi. 10.1111/bph.15964
- By:
- Publication type:
- Article